6 Recruiting Carcinoma, Non-Small-Cell Lung Clinical Trials in Arizona
Explore active carcinoma, non-small-cell lung research studies enrolling across Arizona. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceRecruiting Carcinoma, Non-Small-Cell Lung Studies in Arizona
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
📍 Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers — Chandler, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib
📍 Ironwood Cancer and Research Center — Chandler, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
📍 Arizona Oncology Associates, PC - HAL — Goodyear, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
📍 Banner MD Anderson Cancer Center ( Site 0181) — Gilbert, Arizona
View Study & Checklist ➔ 🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
📍 Banner MD Anderson Cancer Center ( Site 0001) — Gilbert, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
📍 Banner MD Anderson Cancer Center ( Site 0001) — Gilbert, Arizona
View Study & Checklist ➔